Cathcart MSP James Dornan has welcomed the decision by the Scottish Medicines Consortium to approve the use of the prostate cancer drug abiraterone by the NHS in Scotland.

The local MSP has been contacted by a number of constituents who have campaigned for the drug to become available on Scotland’s NHS.

Commenting on the news the local MSP said: “I welcome this decision by the Scottish Medicines Consortium and believe that it will be welcomed by people across my constituency who have campaigned on this issue.

“I’ve met with constituents who are affected personally by prostate cancer; either diagnosed  or have loved ones who have been diagnosed, and I know that they will be extremely happy at this news.

“I’m now hopeful that the drug reach those affected by prostate cancer across Scotland and that those affected will speak to their doctors at the earliest opportunity.

Note:

Further information on the drug